| 1 |
O’connell F, Mylod E, Donlon NE, Heeran AB, Butler C, Bhardwaj A, Ramjit S, Durand M, Lambe G, Tansey P, Welartne I, Sheahan KP, Yin X, Donohoe CL, Ravi N, Dunne MR, Brennan L, Reynolds JV, Roche HM, O’sullivan J. Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma. Cancers 2023;15:1681. [DOI: 10.3390/cancers15061681] [Reference Citation Analysis]
|
| 2 |
Stary D, Bajda M. Taurine and Creatine Transporters as Potential Drug Targets in Cancer Therapy. Int J Mol Sci 2023;24. [PMID: 36835201 DOI: 10.3390/ijms24043788] [Reference Citation Analysis]
|
| 3 |
Zhu S, Han X, Yang R, Tian Y, Zhang Q, Wu Y, Dong S, Zhang B. Metabolomics study of ribavirin in the treatment of orthotopic lung cancer based on UPLC-Q-TOF/MS. Chem Biol Interact 2023;370:110305. [PMID: 36529159 DOI: 10.1016/j.cbi.2022.110305] [Reference Citation Analysis]
|
| 4 |
Feng J, Gong Z, Sun Z, Li J, Xu N, Thorne RF, Zhang XD, Liu X, Liu G. Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer. Front Microbiol 2023;14:1034325. [PMID: 36712187 DOI: 10.3389/fmicb.2023.1034325] [Reference Citation Analysis]
|
| 5 |
Wang X, Zhu X, Li X, Li Z, Mao Y, Zhang S, Liu X, Liu X, Liu Y, Cao F, Zhang J. Transcriptomic and metabolomic analyses provide insights into the attenuation of neuroinflammation by nervonic acid in MPTP-stimulated PD model mice. Food Funct 2023;14:277-91. [PMID: 36484706 DOI: 10.1039/d2fo02595g] [Reference Citation Analysis]
|
| 6 |
Yang B, Zhao F, Li X, Zhao M, Lv J, Shi M, Li J, Zhou Z, Wang J, Song J. Alteration of pro-carcinogenic gut microbiota is associated with clear cell renal cell carcinoma tumorigenesis.. [DOI: 10.1101/2022.12.07.519551] [Reference Citation Analysis]
|
| 7 |
Liu J, Zhou Y, Liu H, Ma M, Wang F, Liu C, Yuan Q, Wang H, Hou X, Yin P. Metabolic reprogramming enables the auxiliary diagnosis of breast cancer by automated breast volume scanner. Front Oncol 2022;12:939606. [DOI: 10.3389/fonc.2022.939606] [Reference Citation Analysis]
|
| 8 |
Ni Z, Xu S, Yu Z, Ye Z, Li R, Chen C, Yang J, Liu H, Zhou Z, Zhang X. Comparison of dual mTORC1/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics. Invest New Drugs 2022. [PMID: 36063263 DOI: 10.1007/s10637-022-01268-w] [Reference Citation Analysis]
|
| 9 |
Kodentsova VM, Risnik DV, Ladodo OB. Functional ingredient taurine: adequate and clinically effective doses. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-14-88-95] [Reference Citation Analysis]
|
| 10 |
Yousuf M, Shamsi A, Mohammad T, Azum N, Alfaifi SYM, Asiri AM, Mohamed Elasbali A, Islam A, Hassan MI, Haque QMR. Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics. ACS Omega. [DOI: 10.1021/acsomega.2c03479] [Reference Citation Analysis]
|
| 11 |
Zhuang J, Yang X, Zheng Q, Li K, Cai L, Yu H, Lv J, Bai K, Cao Q, Li P, Yang H, Wang J, Lu Q. Metabolic Profiling of Bladder Cancer Patients' Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy. Metabolites 2022;12:558. [PMID: 35736490 DOI: 10.3390/metabo12060558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Chen W, Li Q, Hou R, Liang H, Zhang Y, Yang Y. An integrated metabonomics study to reveal the inhibitory effect and metabolism regulation of taurine on breast cancer. Journal of Pharmaceutical and Biomedical Analysis 2022. [DOI: 10.1016/j.jpba.2022.114711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 13 |
Pal LC, Gautam A, Pande V, Rao CV. Anticancer property of Selaginella bryopteris (L.) Bak. against hepatocellular carcinoma in vitro and in vivo. Phytomedicine Plus 2022;2:100201. [DOI: 10.1016/j.phyplu.2021.100201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Li X, Liu L, Li N, Jia Q, Wang X, Zuo L, Long J, Xue P, Sun Z, Zhao H. Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus. J Cancer 2022;13:76-87. [PMID: 34976172 DOI: 10.7150/jca.59777] [Reference Citation Analysis]
|
| 15 |
Ma J, Yang Z, Jia S, Yang R. A systematic review of preclinical studies on the taurine role during diabetic nephropathy: focused on anti-oxidative, anti-inflammation, and anti-apoptotic effects. Toxicol Mech Methods 2022;:1-11. [PMID: 34933643 DOI: 10.1080/15376516.2021.2021579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Marcinkiewicz J, Nagl M, Kyriakopoulos A, Walczewska M, Skóra M, Skalska P. Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-030-93337-1_8] [Reference Citation Analysis]
|
| 17 |
Mock-Ohnesorge J, Mock A, Hackert T, Fröhling S, Schenz J, Poschet G, Jäger D, Büchler MW, Uhle F, Weigand MA. Perioperative changes in the plasma metabolome of patients receiving general anesthesia for pancreatic cancer surgery. Oncotarget 2021;12:996-1010. [PMID: 34012512 DOI: 10.18632/oncotarget.27956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 18 |
Baliou S, Sofopoulos M, Goulielmaki M, Spandidos DA, Ioannou P, Kyriakopoulos AM, Zoumpourlis V. Bromamine T, a stable active bromine compound, prevents the LPS‑induced inflammatory response. Int J Mol Med 2021;47:37. [PMID: 33537817 DOI: 10.3892/ijmm.2021.4870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
